reglab/statecodes huggingface dataset:
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0341 - Compliance Testing Requirements for Finished Inhalable Cannabinoid Products

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A processor
			 or processing site must test every process lot of a finished inhalable
			 Cannabinoid product prior to selling or transferring the product for the
			 following:
(a) Pesticides in accordance with
			 OAR 333-007-0400.
(b) Solvents in
			 accordance with OAR 333-007-0410.
(c) Adult use cannabinoid and CBD
			 concentration in accordance with OAR 333-007-0430.
(d) Heavy metals in accordance with OAR
			 333-007-0415  if the finished inhalable cannabinoid product is or was
			 manufactured on or after March 1, 2023.
(e) Mycotoxins in accordance with OAR
			 333-007-0425  finished inhalable cannabinoid product is or was manufactured on
			 or after July 1, 2022.
(f)
			 Microbiological contaminants in accordance with OAR 333-007-0390  finished
			 inhalable cannabinoid product is or was manufactured on or after March 1,
			 2023.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0342 - Compliance Testing Requirements for Industrial Hemp-Derived Vapor Items

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Every process
			 lot of an industrial hemp-derived vapor item for use by a consumer or patient
			 prior to selling or transferring the item must be tested for the following:
(a) Pesticides in accordance with OAR
			 333-007-0400.
(b) Solvents in
			 accordance with OAR 333-007-0410.
(c) Adult use cannabinoid and CBD
			 concentration in accordance with OAR 333-007-0430.
(d) Heavy metals in accordance with OAR
			 333-007-0415  if the industrial hemp-derived vapor item is or was manufactured
			 on or after March 1, 2023.
(e)
			 Mycotoxins in accordance with OAR 333-007-0425  if the industrial hemp-derived
			 vapor item is or was manufactured on or after July 1, 2022.
(f) Microbiological contaminants in
			 accordance with OAR 333-007-0390  if the industrial hemp-derived vapor item is
			 or was manufactured on or after March 1, 2023.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0345 - Compliance Testing Requirements for Cannabinoid Products

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A processor or processing site must test
			 every process lot of a finished cannabinoid product intended for human
			 consumption, use or ingestion for use by a consumer or patient prior to selling
			 or transferring the cannabinoid product for THC and CBD concentration in
			 accordance with OAR 333-007-0430.
(2) A processor or processing site must test
			 a process lot of a finished cannabinoid product intended for human consumption,
			 use or ingestion for microbiological contaminants in accordance with OAR
			 333-007-0390, upon written request by the Authority or the
			 Commission.
(3) In lieu of ordering
			 and arranging for the sampling and testing required in this rule a processor
			 may transport batches of cannabinoid products referenced in section (1) of this
			 rule to a wholesaler licensed by the Commission under ORS
			 475B.100 and the wholesaler may order and arrange for the sampling and testing of the
			 batches, in accordance with rules established by the Commission.
Statutory/Other Authority: ORS
				  475B.555
Statutes/Other Implemented: ORS
				  475B.555
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0350 - Batch Requirements for Compliance Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Marijuana or usable marijuana.
(a) A producer or grower must separate each
			 harvest lot of marijuana or usable marijuana harvested before July 1, 2022,
			 into no larger than 15 pound batches.
(b) A producer or grower must separate each
			 harvest lot of marijuana or usable marijuana harvested on or after July 1,
			 2022, into no larger than 50.0-pound batches.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0360 - Sampling and Sample Size Requirements for Compliance Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Marijuana or
			 usable marijuana.
(a) Usable marijuana may
			 only be sampled after it is cured, unless the usable marijuana is intended for
			 sale or transfer to a processor or processing site to make a cannabinoid
			 concentrate or extract.
(b) Sample
			 increments taken must in total represent a minimum of 0.5 percent of the batch,
			 consistent with the laboratory's accredited sampling policies and procedures,
			 described in OAR 333-064-0100(2).
(c) A portion of homogenized samples taken
			 from multiple batches of usable marijuana from the same harvest lot as
			 described in OAR 333-064-0100(2)(f)  may be combined into one sample for
			 purposes of testing for adult use cannabinoids and CBD if the batches are the
			 same strain and appear to be substantially similar in appearance and quality,
			 regardless of the size of the multiple batches. Sampling must be performed in
			 accordance with ORELAP-SOP-001 Rev 4.0 and on or after July 1, 2022,
			 ORELAP-SOP-001 Rev 4.1.
(d) The
			 whole batch of marijuana or usable marijuana must be made available for
			 sampling and placed in containers that holds no more than 15 pounds of
			 marijuana or usable marijuana.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0370 - Sampling Personnel Requirements; Sampling Recordkeeping

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Only
			 individuals employed by a laboratory with an ORELAP accredited scope item for
			 sampling under these rules may take samples.
(2) Sampling may only be conducted at a
			 licensee's or registrant's premises or the licensee or registrant may transport
			 the entire batch to a laboratory with an ORELAP accredited scope item for
			 sampling under these rules.
Statutory/Other Authority: ORS
				  475C.544
Statutes/Other Implemented: ORS
				  475C.544
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0380 - Grower and Processing Site Requirements for Labeling, Storing, and Securing Pre-Tested Marijuana Items; Recordkeeping

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Following samples being taken from a
			 harvest or process lot batch a grower or processing site must:
(a) Label the batch with the following
			 information:
(A) The registrant's
			 registration number;
(B) The
			 harvest or process lot unique identification number;
(C) The name and accreditation number of the
			 laboratory that took samples and the name and accreditation number of the
			 laboratory responsible for the testing, if different;
(D) The test batch or sample unique
			 identification numbers supplied by the laboratory personnel;
(E) The date the samples were taken; and
(F) In bold, capital letters, no
			 smaller than 12 point font, "PRODUCT NOT TESTED."
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0390 - Standards for Microbiological Contaminants Compliance Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A marijuana
			 item or industrial hemp-derived vapor item required to be tested for
			 microbiological contaminants under OAR 333-007-0320  to 333-007-0342  must be
			 sampled using appropriate aseptic technique and tested by a laboratory for
			 Shiga toxin-producing Escherichia coli and Salmonella species.
(2) A batch fails microbiological
			 contaminants testing if, during an initial test where no reanalysis is
			 requested or upon reanalysis as described in OAR 333-007-0450(1)  the laboratory
			 detects:
(a) Shiga toxin-producing Escherichia
			 coli in one gram; or
(b) Salmonella
			 spp. in one gram.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0400 - Standards for Pesticides Compliance Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A marijuana item or industrial
			 hemp-derived vapor item required to be tested for pesticides must be tested by
			 a laboratory for all the analytes listed in Exhibit A, Table 3, incorporated by
			 reference.
(2) A batch fails
			 pesticide testing if a laboratory detects the presence of a pesticide above the
			 action levels listed in Exhibit A, Table 3 in any sample, including a
			 duplicate:
(a) During an initial test where
			 no reanalysis is requested; or
(b)
			 Upon reanalysis as described in OAR 333-007-0450(1).
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0410 - Standards for Solvents Compliance Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A marijuana item or industrial
			 hemp-derived vapor item required to be tested for solvents must be tested by a
			 laboratory for all the analytes listed in Exhibit A, Table 4 incorporated by
			 reference.
(2) A batch fails
			 solvent testing if a laboratory, during an initial test where no reanalysis is
			 requested or upon reanalysis as described in OAR 333-007-0450(1):
(a) Detects the presence of a solvent above
			 the action level listed in Exhibit A, Table 4 in a sample;
(b) Calculates a RPD of more than 10 percent
			 between the primary result and the duplicate result if the mean result is
			 greater than half the action level for any analyte listed in Exhibit A, Table
			 4; or
(c) Calculates a RSD of more
			 than 10 percent between the primary result, the duplicate result and any
			 replicate result if the mean result is greater than half the action level for
			 any analyte listed in Exhibit A, Table 4.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0415 - Standards for Heavy Metal Compliance Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A marijuana item or industrial
			 hemp-derived vapor item required to be tested for heavy metals must be tested
			 by a laboratory for the analytes listed in Exhibit A, Table 8 incorporated by
			 reference.
(2) A batch fails heavy
			 metal testing if a laboratory detects the presence of a heavy metal above the
			 action levels listed in Exhibit A, Table 8 in any sample, including a
			 duplicate:
(a) During an initial test where
			 no reanalysis is requested; or
(b)
			 Upon reanalysis as described in OAR 333-007-0450(1).
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0420 - Standards for Testing Water Activity and Moisture Content

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Usable
			 marijuana must be tested by a laboratory for:
(a) Water activity; and
(b) Moisture content.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0425 - Standards for Mycotoxin Contaminants Compliance Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A marijuana item or industrial
			 hemp-derived vapor item required to be tested for mycotoxin must be tested by a
			 laboratory for:
(a) Aflatoxins B1, B2, G1,
			 G2; and
(b) Ochratoxin A.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0430 - Standards for Adult Use Cannabinoid and CBD Compliance Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A laboratory must test for all of the
			 following analytes when testing a marijuana item or industrial hemp-derived
			 vapor item for potency:
(a)
			 Delta-9-THC.
(b)
			 Delta-9-THCA.
(c)
			 Delta-8-THC.
(d) CBD.
(e) CBDA.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0450 - Failed Test Samples

Current through Register Vol. 63, No. 7, July 1, 2024
(1) If a sample
			 or a duplicate sample (collectively referred to as "sample" for purposes of
			 this rule) fails any initial test the laboratory that did the testing may
			 reanalyze the sample. The laboratory that did the initial test may not
			 subcontract the reanalysis. If a primary sample or a duplicate sample fails,
			 both must be reanalyzed. If the sample passes, another laboratory must resample
			 the batch and confirm that result in order for the batch to pass testing.
(a) If a registrant or licensee requests to
			 have a sample reanalyzed, the registrant or licensee must request a reanalysis
			 within seven calendar days from the date the laboratory sent notice of the
			 failed test to the registrant or licensee. The reanalysis must be completed by
			 the laboratory within 30 days from the date the reanalysis was
			 requested.
(b) If a registrant or
			 licensee has requested a reanalysis in accordance with subsection (1)(a) of
			 this rule and the sample passes, the registrant or licensee has seven calendar
			 days from the date the laboratory sent notice of the passed test to request
			 that another laboratory resample the batch and confirm the passed test result.
			 The retesting must be completed by the second laboratory within 30 days from
			 the date the retesting was requested. The second laboratory performing the
			 retesting:
(A) May not be performed at a
			 laboratory under the same ownership as the original laboratory that performed
			 the testing.
(B) May not be done by
			 a laboratory that was subcontracted to do the original testing.
(C) May only conduct retesting for the
			 compliance test that initially failed.
(c) If reanalysis in accordance with
			 subsection (1)(a) or retesting in accordance with subsection (1)(b) is ordered,
			 then the batch must remain in its original quantity as it was initially
			 submitted to the laboratory for testing and may not be subdivided.
(d) A registrant must inform the Oregon
			 Health Authority (Authority) immediately, of the following, in a manner
			 prescribed by the Authority:
(A) A request for
			 reanalysis of a sample;
(B) The
			 testing results of the reanalysis;
(C) A request for retesting; and
(D) The results of retesting.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0470 - Tentative Identification of Compounds

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Tentatively Identified Compounds (TICs)
			 are compounds detected in a sample using gas chromatography mass spectrometry
			 that are not among the target analytes for the residual solvent
			 analysis.
(2) The Authority or
			 Commission may initiate an investigation of a registrant or licensee for TICS
			 and may require a registrant or licensee to submit samples for additional
			 testing, including testing for analytes that are not required by these rules,
			 at the registrant's or licensee's expense.
Statutory/Other Authority: ORS 475C.544
Statutes/Other Implemented: ORS
				  475C.544
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0480 - Audit and Random Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) The
			 Oregon Health Authority (Authority) may require a registrant to submit samples
			 identified by the Authority to a laboratory of the Authority's choosing or the
			 cannabis reference laboratory to be tested in order to determine whether a
			 registrant is in compliance with OAR 333-007-0300  through 333-007-0600  or any
			 other rule of the Authority.
(2) A
			 laboratory doing audit testing under section (1) of this rule must comply with
			 these rules unless otherwise authorized by the Authority.
(3) The Authority may, at any time, require a
			 registrant to permit the sampling of or submit a sample of a marijuana item to
			 the Authority for testing. Such testing may include testing for:
(a) Any microbiological
			 contaminant.
(b) Heavy
			 metals;
(c) Solvents;
(d) Pesticides;
(e) Mycotoxins;
(f) Adulterants, additives, or other
			 contaminants that may pose a risk to public health or safety, or is prohibited
			 by law.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0500 - Quality Control and Research and Development Testing

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A registrant or a licensee may request
			 that a laboratory conduct testing for the purpose of assuring quality control
			 or for research and development, except as provided in section (2) of this
			 rule.
(a) A quality control test result,
			 research and development test result, or test results from testing for any
			 purpose other than compliance testing must be tracked and entered into
			 CTS.
(b) A registrant, licensee, or
			 other requestor must ensure that relevant information regarding the registrant,
			 licensee, or manufacturer of the item is provided to the laboratory conducting
			 the testing in accordance with OAR 333-007-0315.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 7 - MARIJUANA AND HEMP TESTING › Section 333-007-0600 - Cannabis Reference Laboratory

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 The Oregon Health Authority (Authority) may request that the cannabis reference
			 laboratory conduct any of the following:
(a)
			 Audit testing as described in OAR 333-007-0480; or
(b) Testing if the Authority has reason to
			 believe the marijuana item, industrial hemp or hemp item is not in compliance
			 with ORS 475C.544 or these
			 rules.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0010 - Definitions

Current through Register Vol. 63, No. 7, July 1, 2024
For the purposes of OAR chapter 333, division 8 the following
				definitions apply unless otherwise indicated:
(1) "Advertising" means publicizing the trade
			 name of a PRMG, registered processing site or dispensary together with words or
			 symbols referring to marijuana or publicizing the brand name of marijuana or a
			 medical cannabinoid product, concentrate or extract in any medium.
(2) "Adult use cannabinoid" includes, but is
			 not limited to, tetrahydrocannabinols, tetrahydrocannabinolic acids that are
			 artificially or naturally derived, delta-8-tetrahydrocannabinol,
			 delta-9-tetrahydrocannabinol, the optical isomers of
			 delta-8-tetrahydrocannabinol or delta-9 tetrahydrocannabinol and any
			 artificially derived cannabinoid that is reasonably determined to have an
			 intoxicating effect.
(3)
			 "Applicant" means, as applicable to the registration being applied for:
(a) An individual applying for a registry
			 identification card under ORS 475C.783.
(b) An individual applying for a grow site
			 registration under ORS 475C.792.
(c) A person applying for a marijuana
			 processing site registration under ORS 475C.815.
(d) A person applying for a medical marijuana
			 dispensary registration under ORS 475C.833.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0020 - New Registry Identification Card Application Process

Current through Register Vol. 63, No. 7, July 1, 2024
(1) To apply for a
			 registry identification card an individual must submit the following:
(a) An application form, prescribed by the
			 Authority, signed and dated by the applicant.
(b) A legible copy of the individual's valid
			 and current government issued photographic identification that includes the
			 applicant's last name, first name, and date of birth. In lieu of photographic
			 identification, the Authority may in its discretion accept valid and current
			 government issued identification that includes the applicant's last name, first
			 name, and date of birth from applicants under the age 18 or who have
			 demonstrated barriers to accessing services to obtain a photographic
			 identification. The Authority may request additional documentation to
			 authenticate the non-photographic identification.
(c) An APS or written documentation that may
			 consist of relevant portions of the applicant's medical record, signed by the
			 applicant's attending provider within 90 days of the date of receipt by the
			 Authority, which describes the applicant's debilitating medical condition and
			 states that the use of marijuana may mitigate the symptoms or effects of the
			 applicant's debilitating medical condition.
(d) Proof of residency in accordance with OAR
			 333-008-0022.
(e) If applicable, a
			 completed and notarized "Declaration of Person Responsible for Minor" form for
			 a person under 18 years of age, signed and dated by the minor's parent or legal
			 guardian.
(f) An application fee as
			 specified in OAR 333-008-0021.
(g)
			 If applicable, documentation required in OAR 333-008-0021  to qualify for a
			 reduced fee.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0021 - Patient and PRMG New and Renewal Fees

Current through Register Vol. 63, No. 7, July 1, 2024
(1) All fees referenced in this rule are
			 non-refundable.
(2) New and Renewal
			 Application Fee. A patient must pay a $200 application fee unless the applicant
			 qualifies for a reduced or waived fee under section (3) of this rule.
(3) Reduced Fees.
(a) An applicant receiving SSI benefits: $20.
			 In order to qualify for the reduced fee the applicant must submit at the time
			 of application a copy of a current monthly SSI benefit statement showing dates
			 of coverage.
(b) An applicant
			 enrolled in OHP: $50. In order to qualify for the reduced fee the applicant
			 must submit a copy of the applicant's current eligibility statement or
			 card.
(c) An applicant receiving
			 food stamp benefits through the Oregon SNAP: $60. In order to qualify for the
			 reduced fee the applicant must submit at the time of application current proof
			 of his or her food stamp benefits.
(d) An applicant who has served in the Armed
			 Forces of the United States: $20. In order to qualify for the reduced fee the
			 applicant must provide proof of having served in the Armed Forces, such as but
			 not limited to, submitting a Veteran's Administration form DD-214.
(e) An applicant who served in the Armed
			 Forces of the United States and has a total disability rating of at least 50
			 percent as a result of an injury or illness that the veteran incurred or that
			 was aggravated during active military service and who received a discharge or
			 release under other than dishonorable conditions: $0. To qualify for the fee
			 waiver the applicant must provide proof of meeting the qualifications for the
			 waived fee, such as but not limited to submitting a Veteran's Administration
			 Summary of Benefits letter. This only applies to applications received by OMMP
			 on and after January 1, 2022.
(f)
			 The Authority shall notify an applicant who submits a reduced or waived
			 application fee if the applicant is not eligible for the reduced or waived fee
			 and will allow the applicant 14 calendar days from the date of notice to pay
			 the correct application fee or submit current valid proof of eligibility for a
			 reduced or waived fee.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0022 - Proof of Residency

Current through Register Vol. 63, No. 7, July 1, 2024
(1) In order
			 to be approved for a registry identification card, an applicant must be a
			 resident of Oregon.
(2) If an
			 applicant for a registry identification card does not have a valid Oregon
			 driver license or Oregon identification card, the applicant must demonstrate
			 that they are a resident of Oregon by submitting sufficient documentation such
			 as but not limited to a current lease agreement or current utility bill that
			 has the applicant's name and address.
(3) Residency must be maintained by patients
			 while registered with the Authority.
Statutory/Other Authority: ORS 475C.783, 475C.792 &
				  475C.919
Statutes/Other Implemented: ORS
				  475C.783
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0023 - Patient Application Review Process

Current through Register Vol. 63, No. 7, July 1, 2024
(1) The Authority must review a patient
			 application to determine if it is complete.
(2) If an applicant does not provide all the
			 information required in OAR 333-008-0020(1)  or pay the applicable fee the
			 Authority will reject the application as incomplete.
(3) If an applicant does not provide all the
			 information required in OAR 333-008-0020(2) and (3), the Authority must notify
			 the applicant of the information that is missing and allow the applicant 14
			 calendar days to submit the missing information.
(4) The Authority may verify the information
			 on each application, verify any accompanying documentation submitted with an
			 application, or request additional information from the applicant or other
			 individuals named on the application.
(5) If the Authority is unable to verify that
			 the applicant's attending provider meets the definition under OAR 333-008-0010  the applicant will be allowed 30 days to submit a new APS or written
			 documentation from an attending provider meeting the requirements of these
			 rules. Failure to submit the required attending provider documentation is
			 grounds for denial under ORS 475C.783(8) and OAR 333-008-0035.
(6) If an applicant fails to submit
			 information necessary for the Authority to verify information on the
			 application, fails to submit information necessary to verify any accompanying
			 documentation submitted with an application, or fails to cooperate with the
			 Authority in obtaining information related to the application review process,
			 such as but not limited to refusing to sign a disclosure authorization within
			 timeframes established by the Authority, the Authority will reject the
			 application as incomplete.
(7) An
			 applicant whose application is rejected as incomplete may reapply at any time.
			 If the individual reapplies within a year the application fee may be applied
			 toward a new application.
(8) Upon
			 receipt of a complete application, including payment of the required
			 application fee, the Authority must issue a receipt to the applicant verifying
			 that a complete application has been received. A receipt issued under this
			 section has the same legal effect as a registry identification card for 30 days
			 following the date on which the receipt was issued to the applicant. A receipt
			 is only valid for the individual that submitted the application and not a
			 proposed designated primary caregiver, proposed organization or facility
			 caregiver, or proposed PRMG.
(9)
			 The Authority shall approve or deny an application within 30 days after
			 receiving a complete application.
Statutory/Other Authority: ORS 475C.783 & 475C.919
Statutes/Other Implemented: ORS
				  475C.783
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0025 - Person Responsible for a Marijuana Grow Site Criteria; Grow Site Registration Application Review Process

Current through Register Vol. 63, No. 7, July 1, 2024
(1) In order to be a PRMG an individual must:
(a) Be 21 years of age or older.
(b) Not have been convicted of a Class A or
			 Class B felony under ORS
			 475.752 to
			 475.920 for the manufacture or delivery of a controlled substance in Schedule I or
			 Schedule II:
(A) Within the previous two
			 years; or
(B) More than
			 once.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0030 - Approval of New and Renewal Patient Applications

Current through Register Vol. 63, No. 7, July 1, 2024
(1) If the Authority approves a patient
			 application, the Authority shall issue a serially numbered registry
			 identification card to the patient within five business days.
(2) The registry identification card must
			 include, but is not limited to:
(a) The
			 patient's name, address, and date of birth;
(b) The effective date, date of issuance, and
			 expiration date of the registry identification card; and
(c) The designated primary caregiver's name,
			 address, and date of birth, if applicable.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0033 - Approval of New or Renewal PRMG and Grow Site Application; Change of PRMG

Current through Register Vol. 63, No. 7, July 1, 2024
(1) An individual
			 is not authorized to produce marijuana for a patient at a grow site until the
			 Authority has registered the grow site and issued a grow site registration card
			 and a PRMG identification card.
(2)
			 The Authority must register a PRMG and a grow site listed on an application,
			 except as provided in section (8) of this rule, if:
(a) The PRMG:
(A) Meets the age requirements;
(B) Passes the criminal background
			 check;
(C) Has not violated a
			 provision of ORS 475C.770 to 475C.919, ORS 475C.574, ORS 475C.640, OAR chapter
			 333, division 7, these rules, or an ordinance adopted pursuant to ORS 475C.897;
			 and
(D) Pays the applicable
			 fee.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0035 - Denial of Patient Application

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 The Authority may deny a new or renewal patient application if:
(a) The applicant or patient did not provide
			 the information required to be submitted in OAR 333-008-0020;
(b) The Authority determines that the
			 information provided was falsified;
(c) The Authority determines that the
			 applicant or patient violated a provision of ORS 475C.770 to 475C.919, ORS
			 475C.574, ORS 475C.640, OAR chapter 333, division 7, these rules, or an
			 ordinance adopted pursuant to ORS 475C.897.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0037 - Denial of Designation of Caregiver or Person Responsible for a Marijuana Grow Site; Denial of Grow Site Registration

Current through Register Vol. 63, No. 7, July 1, 2024
(1) The Authority may deny a designation of a
			 primary caregiver made under ORS 475C.789 or an organization or facility
			 caregiver made under ORS 475C.791 if the Authority determines that the designee
			 or the patient violated a provision of ORS 475C.770 to 475C.919, ORS 475C.574,
			 475C.640, OAR chapter 333, division 7, these rules, or an ordinance adopted
			 pursuant to ORS 475C.897.
(2) A
			 person whose designation has been denied may not be designated as a caregiver
			 under ORS 475C.789 or 475C.791 for six months from the date of the denial
			 unless otherwise authorized by the Authority.
(3) The Authority may deny a designation of a
			 PRMG if the Authority determines that the applicant or the PRMG violated a
			 provision of ORS 475C.770 to 475C.919, 475C.574, 475C.640, OAR chapter 333,
			 division 7, these rules, or an ordinance adopted pursuant to ORS
			 475C.897.
Statutory/Other Authority: ORS 475C.783, 475C.792 &
				  475C.919
Statutes/Other Implemented: ORS 475C.783 &
				  475C.792
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0040 - Annual Renewal

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A patient
			 shall register on an annual basis to maintain active registration status by
			 submitting:
(a) A renewal application
			 prescribed by the Authority;
(b) An
			 APS signed by the patient's attending provider within 90 days prior to the
			 expiration date of the patient's current card, reconfirming the patient's
			 debilitating medical condition and that the medical use of marijuana mitigates
			 the symptoms of the patient's debilitating medical condition, except as
			 provided in section (2) of this rule; and
(c) The additional information and fees
			 required in OAR 333-008-0020  except that government issued photographic
			 identification for a grower, caregiver or patient is not required to be
			 resubmitted if the applicant previously submitted identification that is
			 unexpired at the time the renewal application is received and the same
			 caregiver or grower is being designated on the patient application as the
			 previous year.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0045 - Notification of Changes

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Patient
			 notification responsibilities.
(a) A patient
			 must notify the Authority within 10 calendar days of any change in the
			 patient's name, mailing address, electronic mail address, telephone number,
			 attending provider, designated primary caregiver, organization or facility
			 caregiver, PRMG, grow site address or residency, on a form prescribed by the
			 Authority.
(b) If the patient is
			 designating a caregiver for the first time or designating a different
			 caregiver, the patient must include all the information and documentation
			 specified in the form and required under OAR 333-008-0020.
(c) If the patient is designating an
			 organization or facility caregiver for the first time or designating a
			 different organization or facility caregiver, the patient must include all the
			 information and documentation specified in the form and required under OAR
			 333-008-0020.
(d) If a patient is
			 adding or changing a PRMG or grow site address the patient must comply with OAR
			 333-008-0047.
(e) Any change in
			 ownership of the premises where the grow site is located if the patient or PRMG
			 is not the owner of the premises or is no longer the owner of the
			 premises.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0047 - Interim Addition or Change of Person Responsible for a Marijuana Grow Site or Grow Site Address

Current through Register Vol. 63, No. 7, July 1, 2024
(1) If a patient
			 is adding a PRMG and grow site address at any time other than when applying for
			 a new or renewal registry identification card, or if a patient is changing a
			 PRMG or grow site address at any time other than when submitting a renewal
			 application for a patient identification card, the patient must:
(a) Submit a PRMG and grow site registration
			 change application, on a form prescribed by the Authority, that includes all
			 the information and documentation specified in the form and required under OAR
			 333-008-0020(4); and
(b) Pay the
			 fee required in OAR 333-008-0021  unless the PRMG is a patient growing only for
			 him or herself.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0049 - Timely Submission to the Oregon Health Authority

Current through Register Vol. 63, No. 7, July 1, 2024
If an applicant or an individual or entity designated on an
				application, patient, designated primary caregiver, organization or facility
				caregiver or PRMG is required to submit information or documentation to the
				Authority by a particular deadline it must be received by the Authority,
				regardless of the method used, by 5 p.m. Pacific Time.
Statutory/Other Authority: ORS 475C.919
Statutes/Other Implemented: ORS
				  475C.919
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0080 - Permissible Amounts of Medical Marijuana for Patients and Caregivers

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A patient, the
			 patient's designated primary caregiver or organization or facility caregiver
			 may jointly possess up to six mature marijuana plants, 12 immature marijuana
			 plants, and 24 ounces of usable marijuana.
(2) A patient or the patient's designated
			 primary caregiver or organization or facility caregiver may only possess
			 cannabinoid products, concentrates or extracts in the amounts described in ORS
			 475C.305.
(3) A patient and
			 designated primary caregiver or organization or facility caregiver must have in
			 their possession, their registry identification card or OMMP identification
			 card when transporting marijuana.
(4) A patient must have, in the patient's
			 possession, their registry identification card when using marijuana in a
			 location other than the residence of the cardholder.
Statutory/Other Authority: ORS 475C.809
Statutes/Other Implemented: ORS
				  475C.809
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0085 - Designated Primary Caregivers and Organization or Facility Caregivers

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A designated
			 primary caregiver may assist their patient with any matter related to the
			 medical use of marijuana, including:
(a) The
			 production of marijuana at the address provided by the patient to the Oregon
			 Health Authority pursuant to ORS 475C.783(2)(f); and
(b) The processing of marijuana into
			 cannabinoid concentrates or medical cannabinoid products.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0090 - Addition of Qualifying Diseases or Medical Conditions

Current through Register Vol. 63, No. 7, July 1, 2024
(1) For the purposes of this rule, the
			 following definitions apply:
(a) DSM means
			 the latest published edition of Diagnostic and Statistical Manual of Mental
			 Disorders.
(b) ICD means the most
			 recent revision of the International Classification of Diseases published by
			 the United Nations-sponsored World Health Organization that provides codes, up
			 to six characters long, to classify diseases and a variety of signs, symptoms,
			 abnormal findings, complaints, social circumstances, and external causes of
			 injury or disease.
(c)
			 Peer-reviewed published scientific study means that a study has been cited by
			 the Cochrane Review, the Institute of Medicine, or PubMed Central.
(d) Petitioner means an individual who has
			 filed a petition in accordance with ORS 475C.913 and this rule.
(e) State Public Health Officer (SPHO) means
			 the individual appointed by the Director of the Authority in accordance with
			 ORS
			 431.045,
			 or his or her designee.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0110 - Oregon Cannabis Commission

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 In addition to any other duty prescribed by law, the Oregon Cannabis Commission
			 (OCC) shall:
(a) Provide advice to the
			 Authority with respect to the administration of ORS 475C.770 to 475C.919,
			 including rules and fees adopted and proposed for adoption under ORS 475C.770 to 475C.919;
(b) Provide advice to
			 the Oregon Liquor and Cannabis Commission with respect to the administration of
			 ORS 475C.005 to 475C.525, insofar as those statutes pertain to patients and
			 designated primary caregivers, as those terms are defined in ORS
			 475C.777;
(c) Develop a long-term
			 strategic plan for ensuring that cannabis will remain a therapeutic option for
			 persons with debilitating medical conditions as defined in ORS
			 475C.777;
(d) Develop a long-term
			 strategic plan for ensuring that cannabis will remain affordable for persons
			 with debilitating medical conditions as defined in ORS 475C.777; and
(e) Monitor and study federal laws,
			 regulations and policies regarding marijuana.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0500 - Request for Grandfathered Grow Site

Current through Register Vol. 63, No. 7, July 1, 2024
(1) An individual or group of individuals may
			 submit a petition, on a form prescribed by the Authority, requesting that a
			 grow site be approved as a grandfathered grow site.
(2) A petition submitted under section (1) of
			 this rule must include:
(a) For all
			 individuals currently growing at the grow site:
(A) Names and contact information.
(B) Copies of legible and valid government
			 issued photographic identification that includes last name, first name, and
			 date of birth.
(C) Copies of all
			 current grow site registration cards issued to the PRMG for the grow
			 site.
(D) An attestation that the
			 PRMG was registered at the grow site on December 31, 2014, and has continuously
			 been registered at the grow site since that date.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0510 - Review of Petition For Grandfathered Grow Site

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Once the Authority has determined that a
			 petition is complete it must:
(a) Conduct a
			 criminal background check on all PRMGs listed on the application;
(b) Verify that:
(A) Each person listed on the application is
			 21 years of age or older;
(B) Each
			 person has a current valid registration card and is currently registered at the
			 grow site;
(C) All the patients
			 listed on the application have valid cards; and
(D) All persons were registered with the
			 Authority on December 31, 2014, at the grow site listed on the application and
			 have been continuously registered at the grow site since the petition was
			 submitted; and
(c) Verify
			 the number of patients each PRMG was producing marijuana for, at that grow site
			 on December 31, 2014.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0520 - Approval of Petition for Grandfathered Grow Site

Current through Register Vol. 63, No. 7, July 1, 2024
(1) The Authority will grant a petition for a
			 grandfathered grow site if, based on the information in the petition and the
			 Authority's review of the petition:
(a) The
			 grow site address is currently registered with the Authority;
(b) The petition includes all PRMGs currently
			 growing at the grow site;
(c) With
			 the exception of any PRMG whose designation was revoked under OAR
			 333-008-0510(2), the PRMGs listed in the petition are qualified to be a
			 PRMG;
(d) All qualified PRMGs
			 listed in the petition were registered at the grow site on December 31, 2014,
			 and were all continuously registered there at the time the petition was
			 submitted; and
(e) The number of
			 patients registered at the grow site would not result in the grow site address
			 exceeding:
(A) For a grow site location within
			 city limits and zoned residential:
(i)
			 Twenty-four mature marijuana plants;
(ii) Forty-eight immature marijuana plants
			 that are 24 inches or more in height; and
(iii) One hundred and forty-four immature
			 marijuana plants that are less than 24 inches in height.
(B) For a grow site location within city
			 limits but not zoned residential or outside city limits:
(i) Ninety-six mature marijuana
			 plants;
(ii) One hundred and
			 ninety-two immature marijuana plants that are 24 inches or more in height; and
(iii) Five hundred and seventy-six
			 immature marijuana plants that are less than 24 inches in height.
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0530 - Denial of Petition for Grandfathered Grow Site

Current through Register Vol. 63, No. 7, July 1, 2024
(1) The Authority must deny a petition for a
			 grandfathered grow site if based on the information in the petition and the
			 Authority's review of the petition:
(a) The
			 grow site address is not currently registered with the Authority;
(b) The petition does not include all PRMGs
			 currently producing marijuana at the grow site;
(c) None of the PRMGs listed in the petition
			 are qualified or the number of PRMGs eligible to produce marijuana at the grow
			 site address would result in the grow site address exceeding the maximum plant
			 limits, depending on the location of the grow site;
(d) Not all of the qualified PRMGs listed in
			 the petition were registered at the grow site on December 31, 2014, or were not
			 all continuously registered there at the time the petition was submitted;
			 or
(e) The number of patients
			 registered at the grow site address exceed the plant limits in ORS
			 475C.806(3)(b) or 475C.806(4)(b).
Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 8 - MEDICAL MARIJUANA › Section 333-008-0540 - Requirements for Grandfathered Grow Sites; Termination of PRMG Designation; Suspension or Revocation of PRMG Registration

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A grandfathered grow site may only have
			 the number of plants authorized by the Authority, based on the number of
			 patients designating the address as a grow site on December 31, 2014. A PRMG
			 producing marijuana at a grandfathered grow site may replace an existing
			 patient with a new patient unless the person's designation has been terminated
			 under ORS 475C.806(6).
(2) If the
			 Authority suspends or revokes the registration of a PRMG that is producing
			 marijuana at a grandfathered grow site the PRMG may not continue to grow at
			 that grow site or any other grow site that has:
(a) For a grow site located within city
			 limits that is zoned residential, a maximum of:
(A) Twelve mature marijuana plants;
(B) Twenty-four immature marijuana plants
			 that are 24 inches or more in height; and
(C) Seventy-two immature marijuana plants
			 that are less than 24 inches in height.